The latest research, 'US Crohn's Disease Market Highlights – 2014', provides the US crohn's disease market analysis, competitive landscape, and crohn's disease drug sales forecast in the US.
The research includes the US crohn's disease market size estimates for 2013, market share forecast for six years to 2019, crohn's disease drugs market share, crohn's disease drugs sales estimates, crohn's disease drugs sales forecast, and crohn's disease late stage pipeline products.This research helps executives track competitor drugs sales and market share in the US crohn's disease market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US crohn's disease market.
SCOPE OF THE REPORT
What are the drugs marketed in the US for treating crohn's disease?
Identify drugs marketed in the US for treating crohn's disease including trade name, molecule name, company, and year of launch.
How big is the US crohn's disease market?
Find out estimates for the US crohn's disease market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
What is my competitor’s drugs market share in the US crohn's disease market?
You will know the market share of leading crohn's disease brands in the US, including generics share.
What are the key molecules in pipeline for crohn's disease?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of crohn's disease. Our coverage includes molecule, mechanism of action, and the originator.
What is the future of the US crohn's disease market?
Gain insights into how the US crohn's disease market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
Future crohn's disease drugs forecast in the US
Find out how crohn's disease drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
Marketed Crohn's Disease Drugs in the US
The US Crohn's Disease Market Analysis
Crohn's Disease Drugs Sales Analysis in the US
Competitive Landscape in the US Crohn's Disease market